十二指肠镜市场 - 全球产业规模、份额、趋势、机会及预测（按产品、应用、最终用户、地区和竞争格局划分），2021-2031年

全球十二指肠镜市场预计将从 2025 年的 1.818 亿美元成长到 2031 年的 2.5053 亿美元，复合年增长率为 5.49%。

这些专用侧视镜主要用于内视镜逆行性造影（ERCP），以观察和治疗胰管和胆管内的病变。市场成长主要受胃肠道疾病盛行率上升和人口老化对微创手术需求增加的推动。美国癌症协会预测，到2024年，美国将新增约66,440例胰臟癌病例，凸显了对强大的诊断和治疗性内视镜设备的迫切需求。

然而，可重复使用医疗器材的再处理过程中持续存在的细菌感染风险，严重阻碍了市场扩张。这些内视镜复杂的机械设计使得彻底清洁和消毒变得困难，从而增加了潜在的感染风险和患者安全隐患。这个问题导致医疗机构加强监管审查，操作流程也更加复杂，大大限制了传统可重复使用十二指肠镜的广泛阻碍因素。

市场驱动因素

全球胰胆及消化器官系统疾病发病率的上升是市场成长的主要驱动因素，持续推高了治疗性介入的需求。胆管结石和恶性肿瘤等疾病发生率的增加，推动了内视镜逆行性造影（ERCP）手术数量的增长，因此需要稳定的高性能器械供应。这种需求的激增也反映在主要企业的财务表现中。例如，波士顿科学公司在2024年3月发布的2023年度报告中指出，其内视镜部门的净销售额达到24.82亿美元，较前一年成长11.7%。此外，胰臟癌行动网在2024年1月的一篇报导中指出，预计2024年将有约51,750名美国人死于胰臟癌，凸显了对高效内视镜介入工具的迫切需求。

同时，为降低交叉感染风险，一次性十二指肠镜的快速普及正在重塑市场格局。可重复使用的十二指肠镜由于其复杂的升降机构难以彻底消毒，持续存在患者间细菌传播的风险。出于安全考虑，医疗机构越来越多地采用无菌一次性内视镜，从而避免了重复处理，并降低了感染风险。这一转变也获得了显着的商业性动力。 Amb A/S 在 2024 年 11 月发布的 2023/24 年度报告中指出，其内视镜解决方案业务的有机收入增长了 19.7%，这主要得益于一次性技术的日益普及。这一趋势反映了整个行业向一次性平台的转变，以确保符合日益严格的感染控制监管标准。

市场挑战

可重复使用器械的再处理过程中持续存在的细菌传播风险是限制全球十二指肠镜市场发展的主要阻碍因素。这些器械复杂的机械设计为清洁和消毒带来了巨大挑战，显着增加了病患感染的可能性。这项安全隐患迫使医疗机构实施严格且耗时的灭菌通讯协定，导致手术量减少和营运成本增加。因此，日益严格的监管和责任风险阻碍了传统重复使用模式的大规模推广，并限制了整体市场成长。

为了支持这项限制，ECRI 将不充分或繁琐的设备清洁程序列为 2024 年第二大医疗技术危害。这项分类说明了整个产业在再处理复杂医疗设备所面临的挑战，并显示了限制可重复使用十二指肠镜领域扩充性的高营运负担。

市场趋势

新一代胆道影像视觉化技术的开发正在改变临床标准，显着提升复杂内视镜手术中黏膜结构的显像效果。先进的影像处理和高清对比模式等创新技术正在取代传统的白光成像，使内视镜医师能够更清晰地观察乳头和胰胆管的解剖结构，从而提高插管成功率。随着医院更新设备以支援更强大的诊断能力，这项技术变革正迅速获得商业性认可。例如，Olympus Corporation在2024年5月发布的「2024财年合併会计」公告中指出，其先进的EVIS X1系列产品在第四季度的销售额约占胃肠内镜总销售额的30%，这表明市场对先进成像平台的需求强劲。

同时，针对一次性内视镜手术的特定报销代码的扩展，正在消除先前阻碍一次性器械普及的财务障碍。随着临床实务中无菌器材的普及，过渡期内实施的转付支付和单独计费代码对于使这些高成本耗材在医疗机构中具有经济可行性至关重要。这种财务支持与一次性十二指肠镜使用量的增加直接相关，因为医院利用这些经济框架来平衡预算。为了佐证这一趋势，波士顿科学公司在2024年10月的第三季财报电话会议上宣布，其内镜部门的Exalt Model D一次性十二指肠镜实现了两位数的销售增长，这表明改进的报销结构正在加速一次性解决方案的商业性扩充性。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球十二指肠镜市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 依产品分类（软式十二指肠镜、硬式十二指肠镜）
  • 透过应用（诊断、治疗）
  • 按最终使用者（医院/诊所、门诊护理中心、其他）
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章 北美十二指肠镜市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

7. 欧洲十二指肠镜市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区十二指肠镜市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东和非洲十二指肠镜市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章 南美洲十二指肠镜市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球十二指肠镜市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Custom Ultrasonics, Inc.
• Fujifilm Holdings Corporation
• Hoya Corporation
• KARL STORZ GmbH & Co. KG
• Olympus Corporation
• PENTAX Medical Company
• Ambu A/S
• Boston Scientific Corporation
• EndoMed Systems
• HOYA Corp.

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Duodenoscopes Market is projected to expand from USD 181.80 Million in 2025 to USD 250.53 Million by 2031, reflecting a CAGR of 5.49%. These specialized lateral-viewing endoscopes are primarily used during Endoscopic Retrograde Cholangiopancreatography to visualize and treat pathologies within the pancreatic and bile ducts. Market growth is largely driven by the rising prevalence of digestive disorders and an aging population that requires minimally invasive interventions. Underscoring this demand, the American Cancer Society projected that an estimated 66,440 individuals in the United States would be diagnosed with pancreatic cancer in 2024, highlighting the necessity for robust diagnostic and therapeutic endoscopic capacities.

However, market expansion is significantly impeded by the persistent risk of bacterial transmission associated with reprocessing reusable devices. The intricate mechanical design of these scopes makes thorough cleaning and disinfection difficult, leading to potential infections and patient safety concerns. This issue has resulted in heightened regulatory scrutiny and operational complexities for healthcare facilities, thereby acting as a critical restraint on the broader adoption of traditional reusable duodenoscopes.

Market Driver

The rising global prevalence of pancreaticobiliary and gastrointestinal disorders serves as the primary catalyst for market growth, creating sustained demand for therapeutic interventions. As the incidence of conditions such as bile duct stones and malignancies increases, the volume of Endoscopic Retrograde Cholangiopancreatography (ERCP) procedures rises, necessitating a consistent supply of high-performance devices. This surge in demand is evident in the financial results of major industry players; for instance, Boston Scientific reported in its '2023 Annual Report' from March 2024 that its Endoscopy segment achieved net sales of $2.482 billion, an 11.7% increase from the prior year. Additionally, the Pancreatic Cancer Action Network noted in a January 2024 article that approximately 51,750 Americans were projected to die from pancreatic cancer in 2024, reinforcing the critical need for effective endoscopic intervention tools.

Concurrently, a rapid shift toward single-use duodenoscopes is restructuring the market landscape to mitigate cross-contamination risks. Reusable devices, due to their complex elevator mechanisms, are difficult to disinfect completely, creating a persistent threat of patient-to-patient bacterial transmission. This safety concern is driving healthcare facilities to adopt sterile, disposable scopes, which eliminate reprocessing requirements and reduce infection liability. This transition is gaining significant commercial traction, as evidenced by Ambu A/S in its 'Annual Report 2023/24' from November 2024, where the company reported organic revenue growth of 19.7% in its Endoscopy Solutions business, attributed to the widening adoption of its single-use technologies. This trend reflects a broader industry move towards disposable platforms to ensure compliance with tightening regulatory infection control standards.

Market Challenge

The persistent risk of bacterial transmission associated with reprocessing reusable devices constitutes a significant restraint on the Global Duodenoscopes Market. The intricate mechanical design of these instruments creates substantial difficulties in cleaning and disinfection, which significantly increases the potential for patient infections. This safety challenge compels healthcare facilities to implement highly rigorous and time-consuming sterilization protocols that reduce procedural throughput and escalate operational costs. Consequently, the heightened scrutiny and liability concerns discourage the widespread uptake of traditional reusable models and hamper overall market growth.

Substantiating this restraint, ECRI ranked insufficient or onerous device cleaning instructions as the second highest health technology hazard in 2024. This classification highlights the industry-wide struggle with reprocessing complex medical instruments, validating the high level of operational burden that restricts the scalability of the reusable duodenoscope segment.

Market Trends

The development of next-generation visualization technologies for biliary imaging is shifting clinical standards by enhancing the visualization of mucosal structures during complex endoscopic procedures. Innovations such as advanced image processing and high-definition contrast modes are increasingly replacing standard white-light imaging, enabling endoscopists to better visualize the papilla and pancreatobiliary anatomy for improved cannulation rates. This technological shift is gaining rapid commercial acceptance as hospitals upgrade their capital equipment to support superior diagnostic capabilities. Highlighting this adoption, Olympus Corporation noted in its 'Consolidated Financial Results for Fiscal 2024' presentation in May 2024 that the sales ratio of the company's advanced EVIS X1 series rose to approximately 30 percent of its total gastrointestinal endoscopy sales in the fourth quarter, signaling a strong market preference for enhanced imaging platforms.

Concurrently, the expansion of specific reimbursement codes for disposable endoscopic procedures is dismantling the financial barriers that historically impeded the uptake of single-use devices. While the clinical shift toward sterile instruments is recognized, the recent implementation of transitional pass-through payments and distinct billing codes has been the decisive factor in making these high-cost consumables economically viable for healthcare providers. This financial enablement is directly correlating with increased utilization rates of disposable duodenoscopes as hospitals leverage these economic frameworks to balance their budgets. Validating this trend, Boston Scientific reported in October 2024 regarding its third-quarter results that its Endoscopy segment achieved double-digit revenue growth for the Exalt Model D single-use duodenoscope, demonstrating how improved reimbursement structures are accelerating the commercial scalability of disposable solutions.

Key Market Players

• Custom Ultrasonics, Inc.
• Fujifilm Holdings Corporation
• Hoya Corporation
• KARL STORZ GmbH & Co. KG
• Olympus Corporation
• PENTAX Medical Company
• Ambu A/S
• Boston Scientific Corporation
• EndoMed Systems
• HOYA Corp.

Report Scope

In this report, the Global Duodenoscopes Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Duodenoscopes Market, By Product

• flexible duodenoscopes
• rigid duodenoscopes

Duodenoscopes Market, By Application

• diagnostics
• therapeutics

Duodenoscopes Market, By End User

• Hospitals & Clinics
• Ambulatory Care Centers
• Others

Duodenoscopes Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Duodenoscopes Market.

Available Customizations:

Global Duodenoscopes Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Duodenoscopes Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (flexible duodenoscopes, rigid duodenoscopes)
  • 5.2.2. By Application (diagnostics, therapeutics)
  • 5.2.3. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Duodenoscopes Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Application
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Duodenoscopes Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Duodenoscopes Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Duodenoscopes Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End User

7. Europe Duodenoscopes Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Application
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Duodenoscopes Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End User
  • 7.3.2. France Duodenoscopes Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Duodenoscopes Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Duodenoscopes Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Duodenoscopes Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End User

8. Asia Pacific Duodenoscopes Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Application
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Duodenoscopes Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End User
  • 8.3.2. India Duodenoscopes Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Duodenoscopes Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Duodenoscopes Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Duodenoscopes Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End User

9. Middle East & Africa Duodenoscopes Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Application
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Duodenoscopes Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End User
  • 9.3.2. UAE Duodenoscopes Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End User
  • 9.3.3. South Africa Duodenoscopes Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End User

10. South America Duodenoscopes Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Application
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Duodenoscopes Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End User
  • 10.3.2. Colombia Duodenoscopes Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End User
  • 10.3.3. Argentina Duodenoscopes Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Duodenoscopes Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Custom Ultrasonics, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Fujifilm Holdings Corporation
• 15.3. Hoya Corporation
• 15.4. KARL STORZ GmbH & Co. KG
• 15.5. Olympus Corporation
• 15.6. PENTAX Medical Company
• 15.7. Ambu A/S
• 15.8. Boston Scientific Corporation
• 15.9. EndoMed Systems
• 15.10. HOYA Corp.

16. Strategic Recommendations

17. About Us & Disclaimer